Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1996
09/24/1996US5559119 Carbamates of rapamycin
09/24/1996US5559117 N-[(4-heteroaryl-1-piperazinyl) alkyl]-2-Benoxazolinines and related compounds and their therapeutic utility
09/24/1996US5559116 Analgesics, antipsychotic agents
09/24/1996US5559115 Oncogene function-inhibitory agent, method for inhibiting oncogene function, and treatment of cancer
09/24/1996US5559114 Treatment of autoimmune disease using 2-amino purine derivatives
09/24/1996US5559113 Imidazole compounds and their therapeutic applications
09/24/1996US5559112 Carbamates of rapamycin
09/24/1996US5559111 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
09/24/1996US5559110 Hiv antiviral, good systemic absorption administered by mouth
09/24/1996US5559108 Antibiotics
09/24/1996US5559107 Regulation of immune response
09/24/1996US5559106 Heterocyclic compounds, their use and preparation
09/24/1996US5559104 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use
09/24/1996US5559103 Inhibition of cellullar binding to a selectin receptor
09/24/1996US5559101 Antitumor, anticarcinogenic, hiv
09/24/1996US5559098 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic
09/24/1996US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof
09/24/1996US5558987 Anxiolytic drug as stress relievers by reducing blood cholecystokinin
09/24/1996US5558879 Controlled release formulation for water soluble drugs in which a passageway is formed in situ
09/24/1996US5558877 For vaginal insertion, silicone elastomer ring, tamoxifen
09/24/1996US5558876 Topical ophthalmic acidic drug formulations
09/24/1996US5558872 Gelled mineral oil skin protectant
09/24/1996US5558871 Vegetable oil
09/24/1996US5558870 Method for maintaining a continuously-saturated level of ascorbic acid in a patient's body
09/24/1996CA2172436A1 Compositions and methods for increasing the immunogenicity of tumor cells
09/24/1996CA2087145C Composition for accelerating wound healing
09/24/1996CA2046533C Treatment of endometriosis
09/24/1996CA2022538C N-(vincristinoyl-23) and n-(noranhydro-5'vinblastinoyl-23) derivatives of amino-1 methylphosphonic acid, process for their preparation and pharmaceutical compositions containing the same
09/24/1996CA1338607C Process for the preparation of 3-exomethylenecepham derivatives
09/22/1996CA2172211A1 Treatment and prevention of prostatic cancer
09/22/1996CA2172111A1 Nanosuspensions for intravenous administration
09/22/1996CA2172110A1 Pharmaceutical carriers for nanosuspensions
09/19/1996WO1996028730A1 Method of identifying molecules that regulate fgf activity
09/19/1996WO1996028555A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same
09/19/1996WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996WO1996028476A1 Process for glucan preparation and therapeutic uses of glucan
09/19/1996WO1996028471A1 Modulators of amyloid aggregation
09/19/1996WO1996028465A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028463A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028462A1 17-difluoromethylene-oestratrienes
09/19/1996WO1996028453A1 Processes for the production of 2-isocephem derivatives
09/19/1996WO1996028452A1 Process for the preparation of pharmaceutically acceptable salts of clavulanic acid
09/19/1996WO1996028448A1 6-ARYL PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028446A1 SUBSTITUTED N-CYCLOALKYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4 AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028441A1 Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists
09/19/1996WO1996028435A1 Cephalomannine epoxide, its analogues and a method for preparing the same
09/19/1996WO1996028430A1 Trisubstituted phenyl derivatives
09/19/1996WO1996028429A1 6-SUBSTITUTED PYRAZOLO [3,4-d] PYRIMIDIN-4-ONES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028425A1 Piperidinyl-2-alkyl subst. linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation
09/19/1996WO1996028424A1 Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
09/19/1996WO1996028418A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
09/19/1996WO1996028412A1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
09/19/1996WO1996028403A1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION
09/19/1996WO1996028188A2 Method of transmitting target-oriented substances
09/19/1996WO1996028187A1 Method for treating amyloidosis
09/19/1996WO1996028185A2 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
09/19/1996WO1996028183A1 Method for treatment of autoimmune diseases using interferon-tau
09/19/1996WO1996028178A1 Polyphenol fractions of tea, the use thereof and formulations containing them
09/19/1996WO1996028170A1 Reduced toxicity compositions and methods for treating hiv infections
09/19/1996WO1996028168A1 Methods for the treatment of thrombosis
09/19/1996WO1996028167A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6
09/19/1996WO1996028166A1 Osteoporosis remedy and osteogenesis accelerator
09/19/1996WO1996028165A1 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women
09/19/1996WO1996028164A1 Remedy for pancreatitis
09/19/1996WO1996028163A1 Adenosine as a positive inotrop in the compromised heart
09/19/1996WO1996028162A1 New drug combination for the treatment of viral diseases
09/19/1996WO1996028161A1 Use of a 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole derivative for treating allergic conjunctivitis
09/19/1996WO1996028160A1 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties
09/19/1996WO1996028159A1 SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
09/19/1996WO1996028158A1 Benzamide derivative for treating incontinence
09/19/1996WO1996028157A1 Pharmaceutical compositions containing l-etrabamine, uses thereof, and methods for preparing same
09/19/1996WO1996028156A1 Novel benzothiophene compounds and methods
09/19/1996WO1996028155A1 Novel benzothiophene pharmaceutical compounds
09/19/1996WO1996028154A2 Use of anti-oestrogens as male contraceptives
09/19/1996WO1996028153A1 Method of reducing prolonged coagulation time
09/19/1996WO1996028152A1 Novel benzofuran pharmaceutical compounds
09/19/1996WO1996028151A2 Use of a pyruvate dehydrogenase activator for the treatment of ischaemia in limbs
09/19/1996WO1996028149A1 The pharmacological use of certain cystine derivatives
09/19/1996WO1996028148A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
09/19/1996WO1996028147A1 Injury and mucous membrane antiseptics containing magnesium perphthalate
09/19/1996WO1996028146A1 Novel naphthyl pharmaceutical compounds
09/19/1996WO1996028145A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility
09/19/1996WO1996028144A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
09/19/1996WO1996028142A1 Method and kit for preventing erectile dysfunction
09/19/1996WO1996028141A1 Improvements in or relating to organic compositions
09/19/1996WO1996028136A1 Sunscreen compositions comprising a mixture of titanium and/or zinc oxide particles, method for preparing the same and use thereof
09/19/1996WO1996028114A1 Antioxidant-induced apoptosis in vascular smooth muscle cells
09/19/1996WO1996028025A1 Inactivation of pathogens in blood and/or blood products using formaldehyde
09/19/1996WO1996028008A2 Novel cosmetic or dermatological compositions for controlling skin ageing
09/19/1996WO1996019233A3 Irrigation solution and method for inhibition of pain, inflammation and spasm
09/19/1996WO1996017936A3 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
09/19/1996WO1996010999A3 Lta4 hydrolase inhibitor pharmaceutical compositions and methods of use
09/19/1996WO1992018474A3 Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
09/19/1996DE19510862A1 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle Use of antiestrogens for male birth control
09/19/1996DE19510861A1 Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen Einmonatsspritze as depot contraceptive and hormone replacement therapy for premenopausal women and peri-
09/19/1996DE19509828A1 Oil-in-water emulsion for parenteral admin. contg. EDTA as antimicrobial agent
09/19/1996DE19509729A1 17-Difluormethylen-Estratriene 17-difluoromethylene estratrienes
09/19/1996DE19509663A1 Verfahren zur Isolierung von Galanthamin A method for the isolation of galanthamine
09/19/1996DE19509036A1 Skin preparation for the absorption of the cofactor biotin
09/19/1996CA2215391A1 Method of identifying molecules that regulate fgf activity
1 ... 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 6891 6892 6893 6894 6895 6896 6897 6898 ... 7860